Sources of Funding: This study was funded by Janssen Animal Health, Beerse, Belgium, which was acquired by Elanco in July 2011.
The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries
Version of Record online: 31 MAY 2013
© 2013 The Authors. Veterinary Dermatology published by John Wiley & Sons on behalf of the ESVD and ACVD.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Volume 24, Issue 4, pages 439–e97, August 2013
How to Cite
Pietschmann, S., Meyer, M., Voget, M. and Cieslicki, M. (2013), The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries. Veterinary Dermatology, 24: 439–e97. doi: 10.1111/vde.12037
Conflict of Interest: Michael Cieslicki is a full-time employee of Elanco. Michael Voget is head of ECON GmbH, a Contract Research Organization mainly involved in regulatory affairs for the pharmaceutical industry. Silvia Pietschmann and Michael Meyer have stated that they have no conflicts of interest.
- Issue online: 13 JUL 2013
- Version of Record online: 31 MAY 2013
- Manuscript Accepted: 15 APR 2013
|vde12037-sup-0001-FigS1.doc||Word document||34K||Figure S1. MBC/MIC ratios of polymyxin B or miconazole for bacterial isolates from all countries.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.